Project Number 5R21AT008997-02 Agency/Funding Organization NCCIH Funding Year 2017 View Full Project Details for PROCYANINDIN A-TYPE DIMER: A NOVEL INHIBITOR OF TAU AGGREGATION IN VIVO Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator LEW, JOHN Principal Investigator First Name JOHN Principal Investigator Last Name LEW Awardee Organization J. DAVID GLADSTONE INSTITUTES Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-13-303: NIH Exploratory/Developmental Research Grant Program (Parent R21) FY Overall Cost $191,875 Funding Organization Agency/Funding Organization NCCIH Funding Organization Country United States Program Official HOPP, CRAIG
